Ganglioside-exposed dendritic cells inhibit T-cell effector function by promoting regulatory cell activity

Area of Science:

• Immunology
• Cancer Biology
• Cellular Immunology

Background:

• Tumor pathogenesis involves an immunosuppressive microenvironment that inhibits anti-tumor immune responses.
• Regulatory cells, like myeloid-derived suppressor cells and regulatory T cells, are key contributors to this immunosuppression.
• Tumor-derived gangliosides possess immunomodulatory properties, potentially initiating the immunosuppressive environment.

Purpose of the Study:

• To investigate the immunomodulatory effects of gangliosides on antigen-specific T-cell activation and differentiation.
• To elucidate the role of gangliosides in shaping T-cell responses within the tumor microenvironment.

Main Methods:

• Developed an in vitro system using ganglioside-treated murine bone marrow-derived dendritic cells.
• Primed and activated antigen-specific CD4(+) T cells from AND T-cell receptor transgenic mice.
• Assessed dendritic cell phenotype (CD86 expression, cytokine production) and T-cell responses (proliferation, effector cell development, regulatory activity).

Main Results:

• Ganglioside treatment altered dendritic cells, reducing CD86 expression and decreasing interleukin-12 and -6 production.
• CD4(+) T cells primed by ganglioside-treated dendritic cells proliferated normally but showed impaired T helper effector cell development.
• This impairment was linked to the induction of regulatory T-cell activity, which suppressed previously activated T helper cells via contact-dependent mechanisms.

Conclusions:

• Ganglioside-exposed dendritic cells promote regulatory T-cell activity.
• This induced regulatory T-cell activity can have sustained negative impacts on the development of tumor-specific immune responses.
• Gangliosides represent a critical factor in establishing an immunosuppressive tumor microenvironment.